相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies
L. Li et al.
OBESITY REVIEWS (2016)
The intersection of nonalcoholic fatty liver disease and obesity
Jennifer A. Woo Baidal et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
Ting Guo et al.
SCIENTIFIC REPORTS (2016)
Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells
Xin Wang et al.
ANTI-CANCER DRUGS (2015)
Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation
Xian Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Aijaz Ahmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway
Yong Zhang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Inhibition of Tanshinone IIA, Salvianolic Acid A and Salvianolic Acid B on Areca Nut Extract-Induced Oral Submucous Fibrosis in Vitro
Jian-Ping Dai et al.
MOLECULES (2015)
Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease
W. Shan et al.
CELL DEATH & DISEASE (2015)
P311 promotes renal fibrosis via TGFβ1/Smad signaling
Zhihui Yao et al.
SCIENTIFIC REPORTS (2015)
Thioredoxin-Interacting Protein: a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice
Tauheed Ishrat et al.
MOLECULAR NEUROBIOLOGY (2015)
Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats
Hua-Ying Fan et al.
SCIENTIFIC REPORTS (2015)
Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease
Wenjing Zeng et al.
SCIENTIFIC REPORTS (2015)
Salvianolic Acid A Prevents the Pathological Progression of Hepatic Fibrosis in High-Fat Diet-Fed and Streptozotocin-Induced Diabetic Rats
Guifen Qiang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2014)
RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice
Yong-Hyun Han et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
Yi Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Salvianolic Acid B Inhibited PPARγ Expression and Attenuated Weight Gain in Mice with High-Fat Diet-Induced Obesity
Peijian Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
The thioredoxin antioxidant system
Jun Lu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling
Hui Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Constitutive NLRP3 Activation: Too Much of a Bad Thing
Wajahat Z. Mehal
HEPATOLOGY (2014)
Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo
Min-Jung Park et al.
JOURNAL OF HEPATOLOGY (2014)
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
Xiang Zhang et al.
JOURNAL OF HEPATOLOGY (2014)
Thioredoxin-Interacting Protein Stimulates Its Own Expression via a Positive Feedback Loop
Junqin Chen et al.
MOLECULAR ENDOCRINOLOGY (2014)
Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Soo Jin Yang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Activation of NLRP3 inflammasome by crystalline structures via cell surface contact
Aswin Hari et al.
SCIENTIFIC REPORTS (2014)
Non-alcoholic fatty liver disease
Naveed Sattar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats
Wei Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
ChRIEBP in NASH - A liver transcription factor comes in from the cold
Michael R. Charlton
JOURNAL OF HEPATOLOGY (2013)
Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer
Jianbiao Zhou et al.
MITOCHONDRION (2013)
Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
Alexandra K. Leamy et al.
PROGRESS IN LIPID RESEARCH (2013)
Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice
Xiaomei Xu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Novel insights into ChREBP regulation and function
Gaelle Filhoulaud et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Anabela P. Rolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family
Cees J. Tack et al.
IMMUNOLOGICAL REVIEWS (2012)
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
Fadila Benhamed et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver
Renaud Dentin et al.
JOURNAL OF HEPATOLOGY (2012)
Inflammasomes in health and disease
Till Strowig et al.
NATURE (2012)
A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation?
Haitao Wen et al.
NATURE IMMUNOLOGY (2012)
O-G1cNAcylation Increases ChREBP Protein Content and Transcriptional Activity in the Liver
Celine Guinez et al.
DIABETES (2011)
Induction and Activation of Adaptive Immune Populations During Acute and Chronic Phases of a Murine Model of Experimental Colitis
Lindsay J. Hall et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Genetic control of de novo lipogenesis: role in diet-induced obesity
Maggie S. Strable et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Recent advances in nonalcoholic fatty liver disease
Onpan Cheung et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
Julien Bricambert et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
Thioredoxin-Binding Protein-2 Deficiency Enhances Methionine-Choline Deficient Diet-Induced Hepatic Steatosis But Inhibits Steatohepatitis in Mice
Md. Kaimul Ahsan et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2009)
How should we manage patients with non-alcoholic fatty liver disease in 2007?
Henry L-Y Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice
Renaud Dentin et al.
DIABETES (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation
R Dentin et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
分享论文
